Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BDP9066 is a potent and selective MRCK inhibitor, inhibits MRCKβ and MRCKα/β, and can be used for the prevention and treatment of skin cancer.
説明 | BDP9066 is a potent and selective MRCK inhibitor, inhibits MRCKβ and MRCKα/β, and can be used for the prevention and treatment of skin cancer. |
ターゲット&IC50 | MRCKβ (SCC12 cells):64 nM, MRCKα/β:(ki)0.0136 nM/0.0233 nM, MRCKα/β:0.0136 nM/0.0233 nM ( Ki) |
In vitro | Among over 750 human cancer cell lines tested, BDP9066 consistently exhibited anti-proliferative activity in hematologic cancer cells[1]. |
In vivo | As an effective and selective MRCK inhibitor, BDP9066, in a two-stage chemical carcinogenesis model of mouse squamous cell carcinoma, reduced MRCKα S1003 phosphorylation and the growth of skin tumors with local treatment. |
分子量 | 348.44 |
分子式 | C20H24N6 |
CAS No. | 2226507-04-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 8 mg/mL (22.96 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BDP9066 2226507-04-4 Cell Cycle/Checkpoint Cytoskeletal Signaling Stem Cells ROCK BDP 9066 BDP-9066 Inhibitor inhibitor inhibit